Clinical trial
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With…
NCT00005024 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00005024 |
|---|---|
| Title | Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease |
| Official title | A Double-blind, Multicenter, Parallel Study Comparing the Efficacy and Safety of Kytril Tablets With Placebo, in the Prevention of Nausea and Vomiting During the Days Following Administration of IV Cyclophosphamide-based or Carboplatin-based Chemotherapy in Patients With Malignant Disease |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | carboplatin, cyclophosphamide, doxorubicin hydrochloride, granisetron hydrochloride |
| First posted | Aug 23, 2004 |
| Last update posted | Jan 6, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: